SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 145 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $95,048 | -16.5% | 6,546 | +20.3% | 0.00% | 0.0% |
| Q2 2023 | $113,880 | +11.6% | 5,441 | +12.6% | 0.00% | 0.0% |
| Q1 2023 | $102,052 | -1.8% | 4,832 | +23.1% | 0.00% | 0.0% |
| Q4 2022 | $103,895 | +10.5% | 3,925 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $94,000 | +40.3% | 3,925 | +11.3% | 0.00% | +33.3% |
| Q2 2022 | $67,000 | +9.8% | 3,525 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $61,000 | -20.8% | 3,525 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $77,000 | +14.9% | 3,525 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $67,000 | +9.8% | 3,525 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $61,000 | +15.1% | 3,525 | +48.1% | 0.00% | 0.0% |
| Q1 2021 | $53,000 | 0.0% | 2,380 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $53,000 | +51.4% | 2,380 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $35,000 | 0.0% | 2,380 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $35,000 | +75.0% | 2,380 | +32.1% | 0.00% | +100.0% |
| Q1 2020 | $20,000 | +122.2% | 1,801 | +80.1% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $14,000 | +366.7% | 1,000 | +172.5% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 367 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | -20.0% | 367 | 0.0% | 0.00% | – |
| Q2 2017 | $5,000 | 0.0% | 367 | 0.0% | 0.00% | – |
| Q1 2017 | $5,000 | – | 367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |